Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 1, 1998, Pages 28-31

  Lindgren, A C ^a   Hagenas L ^a   Muller J ^b   Blichfeldt, S ^b   Rosenborg, M ^a   Brismar, T ^a   Ritzen E M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Rigshospitalet   (Denmark)

Author keywords

Growth hormone treatment; IGF I; Prader Willi syndrome

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BODY COMPOSITION; BODY GROWTH; BODY MASS; CHILD; CHROMOSOME 15Q; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENETIC DISORDER; GROWTH REGULATION; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS FUNCTION; MALE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SHORT STATURE;

BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; OBESITY; PRADER-WILLI SYNDROME; PROGNOSIS; REGRESSION ANALYSIS;

EID: 0031933868     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850157822     Document Type: Article

References (24)

1. Cassidy SB. Prader Willi syndrome. Curr Prob Pediatr 1984; 14: 1-55
2. Ruvacalba RHA, Holm VA. Effects of growth hormone in Prader-Willi syndrome. Clin Pediatr 1993; 32: 292-5
3. Angulo M, Castro-Magana M, Uly J. Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrin 1991; 3: 167-73
4. Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrell RE. The Prader-Willi Syndrome: A study of 40 patients and review of the literature. Medicine 1983; 62: 59-80
5. Bengtsson BÅ, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, et al. Treatment of adults with growth hormone deficiency with recombinant GH. J Clin Endocrinol Metab 1993; 76: 309-17
6. Rosenbaum M, Germer J, Leibel R. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH deficient children. J Clin Endocrinol Metab 1989; 69: 1274-81
7. Lee PDK, Wilson DM, Hintz RL, Rosenfeld RG. Growth hormone treatment of short stature in Prader-Willi syndrome. J Pediatr Endocrinol 1987; 2: 31-4
8. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 1996; 3: 393-9
9. Lee PDK, Hwu K, Henson H, Brown BT, Bricker JT, LeBlanc AD, et al. Body composition studies in Prader-Willi syndrome: Effects of growth hormone therapy. In: Ellis KJ, Eastman JD, editors. Human body composition. New York: Plenum Press, 1993
10. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993; 91: 398-402
11. Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 1991; 88: 853-60
12. Luthman M, Jónsdóttir I, Skoog B, Wivall I-L, Roos P, Werner S. Monoclonal antibodies reveal circulating growth hormone of high molecular weight not detectable by conventional assays. Acta Endocrinol 1990; 123: 317-23
13. Bang P, Eriksson U, Sara V, Wivall I-L, Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol 1991; 124: 620-9
14. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jörgensen K, et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents and adults: Relation to age, sex, stage of puberty, testicular size and body mass index. J Clin Endocrinol Metab 1994; 3: 744-52
15. Grill V, Pigon J, Hartling SG, Binder C, Efendic S. Effects of dexamethasone on glucose-induced insulin and pro-insulin release in low and high responders. Metabolism 1990; 39: 251-8
16. 1c by a new liquid-chromatographic assay: Methodology, clinical utility and relation to glucose tolerance evaluated. Clin Chem 1986; 32: 1867
17. Karlberg P, Taranger J, Engström I, Lichtenstein H, Svennberg-Redegren I. The somatic development of children in a Swedish urban community. Acta Paediatr Scand 1976; 66 Suppl 258: 7-76
18. Rolland-Cachera MF, Sempé M, Guilloud-Bataille M, Patois E, Pérquignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178-84
19. Tanner JM, Whitehouse RH, Cameron N, Marshall Wa, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2 method). 2nd ed. London: Academic Press, 1983
20. Albertsson-Wikland K, Aronson S, Nilsson KO, Ritzen M, Tuvemo T, Westgren U, et al. Recombinant somatropin in treatment of growth hormone deficient children in Sweden and Finland. Acta Paediatr Scand 1988 ; 77 Suppl 347: 176-9
21. Wit J-M, Boersma B, de Muinck Keizer-Schramat SMPF, Nienhuis HE, Oostdijk V, Otten BJ, et al. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Clin Endocrinol 1995; 42: 365-72
22. Vanderschueren-Lodeweyckx M. The effects of simple obesity on growth and growth hormone. Horm Res 1993; 40: 23-30
23. Ritzén EM, Bolme P, Hall K. Endocrine physiology and therapy in Prader-Willi syndrome. In: Cassidy SB, ed. Prader-Willi Syndrome, NATO ASI Series, Vol H 61, Heidelberg: Springer-Verlag, 1992: 154-69
24. Orme SM, Sebastian JP, Oldroyd B, Stewart SP, Grant PJ, Stickland MH, et al. Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol 1992; 37: 453-9